Literature DB >> 28837605

Regio- and enantioselective microbial hydroxylation and evaluation of cytotoxic activity of β-cyclocitral-derived halolactones.

Marcelina Mazur1, Witold Gładkowski1, Višnja Gaurina Srček2, Kristina Radošević2, Gabriela Maciejewska3, Czesław Wawrzeńczyk1.   

Abstract

Three β-cyclocitral-derived halolactones, which exhibit antifeedant activity towards storage product pests, were subjected to microbial transformation processes. Among the thirty tested strains of filamentous fungi and yeast, the most effective biocatalysts were Absidia cylindrospora AM336, Mortierella isabellina AM212 and Mortierella vinaceae AM149. As a result of regio- and enantioselective hydroxylation four new oxygenated derivatives were obtained. Regardless of the biocatalyst applied, the δ-iodo- and δ-bromo-γ-lactones were hydroxylated in an inactivated position C-5 of cyclohexane ring. The analogous transformation of chlorolactone was observed in Mortierella isabellina AM212 culture but in the case of two other biocatalysts the hydroxy group was introduced at C-3 position. All obtained hydroxylactones were enantiomerically pure (ee = 100%) or enriched (ee = 50%). The highest enantioselectivity of hydroxylation was observed for M. isabellina AM212. The cytotoxic activity of halolactones was also examined by WST-1 assay wherein tested compounds did not exhibit significant effect on the viability of tumor HeLa and normal CHO-K1 cells.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28837605      PMCID: PMC5570294          DOI: 10.1371/journal.pone.0183429

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

The hydroxylation of “inactivated” position in substrate structure leading to enantiomerically pure or enriched products arouse great interest but it is difficult to carry out by traditional chemical synthesis. One of the most efficient methods of incorporation the hydroxy group into organic molecule is the application of microorganisms [1,2,3]. It is also worth to notice that processes catalyzed by the microorganisms have less harmful impact on natural environment than methods of organic synthesis [4]. The biotransformations catalyzed by whole cells are convenient and useful biotechnological tools, especially taking into consideration that majority of hydroxylation processes are mediated by membrane enzymes hence they cannot be easily purified. Different microorganisms can be applied to the enantioselective hydroxylation processes [5, 6]. In our present work we tested thirty strains of filamentous fungi and yeast from seventeen different genus. Three strains of filamentous fungi from Absidia and Mortierella genus were found to be efficient catalysts. The different Mortierella species are investigated as a potent producer of arachidonic acid but only few examples of their use for biohydroxylation are described in literature [7-9]. More examples of hydroxylation can be found for Absidia genus [10-12]. Different Absidia strains are able to transform biologically active compounds [13,14], including those with steroid skeleton [15,16] or lactone ring [17-21]. In this work we present the hydroxylation of β-cyclocitral-derived halolactones by three fungal strains (Absidia cylindrospora AM336, Mortierella isabellina AM212 and Mortierella vinaceae AM149). Parent compounds exhibit antifeedant activity [22] hence it is important to establish the possible metabolic pathway of those compounds in natural environment. Biotransformations of halolactones involving the hydroxylation reaction which entails the increase of their polarity is essential during their further biodegradation. Additionally the previous reports revealed the anticancer potential of some δ-halo-γ-lactones [23, 24] which prompted us to check also the cytotoxic activity of halolactones derived from β-cyclocitral.

Material and methods

Analysis

The progress of transformations as well as the purity of isolated products were checked by Thin Layer Chromatography (TLC, silicagel couted aluminium plates, DC-Alufolien Kieselgel 60 F254, Merck) and gas chromatography (GC). GC analysis was performed on a Agilent Technologies 6890N instrument using Agilent DB-17 capillary column ((50%-phenyl)-methylpolysiloxane 30 m × 0.25 mm × 0.25 μm) and the hydrogen as the carrier gas. The temperature programme was as follows: injector 250°C, detector (FID) 300°C, column temperature: 80°C (1min), 80–200°C (rate 20°C min−1), 200–300°C (rate 30°C min−1), 300°C (2 min). The enantiomeric excesses of biotransformation products were calculated on the basis of GC analysis using CP Chirasil-Dex CB column (25 m x 0.25 mm x 0.25 μm) at the following conditions: injector 200°C, detector (FID) 250°C, column temperature: 75°C (hold 1 min), 75–190°C (rate 0.42°C min-1), 190°C (hold 1 min), 190–200 (rate 0.5°C min-1), 200°C (hold 10 min). The biotransformation products were purified by column chromatography on silica gel (Kieselgel 60, 230–400 mesh, Merck). The NMR spectra (1H, 13C NMR and correlation spectra: 1H-1H COSY, 1H-13C HMQC, 1H-13C HMBC) were recorded in a CDCl3 solution on a Brüker Avance II 600 MHz spectrometer. Residual solvent signals (δH = 7.26, δC = 77.0) were used as references for chemical shifts. IR spectra were determined using Mattson IR 300 Thermo Nicolet spectrophotometer. The melting points (uncorrected) were determined on a Boetius apparatus. Optical rotations were measured on Jasco P-2000 digital polarimetr (version with iRM controller). High resolution mass spectra (HRMS) were recorded using electron spray ionization (ESI) technique on spectrometer Waters ESI-QTOF Premier XE.

Substrates for biotransformation

Three racemic lactones containing different halogen atoms: 1-iodomethyl-2,2,6-trimethyl-9-oxabicyclo [4.3.0]nonan-8-one (1), 1-bromomethyl-2,2,6-trimethyl-9-oxabicyclo[4.3.0]nonan-8-one (2) and 1-chloromethyl-2,2,6-trimethyl-9-oxabicyclo[4.3.0]nonan-8-one (3) were synthesized from β-cyclocitral in four steps chemical synthesis, according to the procedure described earlier [22]. Here we present the spectral data of those compounds in order to compare them with the spectra of corresponding products of microbial transformations. 1-Iodomethyl-2,2,6-trimethyl-9-oxabicyclo [4.3.0]nonan-8-one (1) mp = 104–107°C; H NMR (600 MHz, CDCl3)δ: 1.10 and 1.17 (two s, 6H, (CH3)2C<), 1.34 (s, 3H, CH3-6), 1.38–1.75 (m, 6H, CH2-4, CH2-5, CH2-6), 2.21 and 3.26 (two d, J = 17.5 Hz, 2H, CH2-7), 3.52 and 3.84 (two d, J = 11.8 Hz, 2H, CH2-10); C NMR (151 MHz, CDCl3) δ: 6.09 (C-10), 17.26 (C-4), 21.74 (CH3-6), 25.53 and 27.63 ((CH3)2C<), 38.18 (C-2), 38.31 (C-3), 39.86 (C-5), 42.39 (C-6), 47.84 (C-7), 88.02 (C-1), 175.62 (C-8); IR (KBr, cm-1): 2928 (s), 1767 (s), 1245 (m), 633 (w); 1-Bromomethyl-2,2,6-trimethyl-9-oxabicyclo [4.3.0]nonan-8-one (2) mp = 156–161°C; H NMR (600 MHz, CDCl3) δ: 1.07, 1.15 (two s, 6H, (CH3)2C<), 1.37 (s, 3H, CH3-6), 1.38 (m, 1H, one of CH2-3), 1.42–1.48 (m, 2H, one of CH2-4 and one of CH2-5), 1.53 (m, 1H, one of CH2-4), 1.62–1.71 (m, 2H, one of CH2-3 and one of CH2-5), 2.17 and 3.25 (two d, J = 17.5 Hz, 2H, CH2-7), 3.73 and 3.97 (two d, J = 11.9 Hz, 2H, CH2-10); C NMR (151 MHz, CDCl3) δ: 17.42 (C-4), 21.90 (CH3-6), 25.34 and 27.43 ((CH3)2C<), 35.15 (C-10), 38.07 (C-2), 38.57 (C-3), 40.08 (C-5), 42.07 (C-6), 47.85 (C-7), 88.67 (C-1), 175.93 (C-8); IR (KBr, cm-1): 2976 (s), 1767 (s), 1243 (s), 656 (m); 1-Chloromethyl-2,2,6-trimethyl-9-oxabicyclo [4.3.0]nonan-8-one (3) mp = 97–101°C; H NMR (600 MHz, CDCl3) δ: 1.05, 1.14 (two s, 6H, (CH3)2C<), 1.34 (m, 1H, one of CH2-3), 1.36 (s, 3H, CH3-6), 1.42–1.48 (m, 2H, one of CH2-4 and one of CH2-5), 1.53 (m, 1H, one of CH2-4), 1.61–1.70 (m, 2H, one of CH2-3 and one of CH2-5), 2.16 and 3.14 (two d, J = 17.4 Hz, 2H, CH2-7), 3.88 and 4.05 (two d, J = 12.6 Hz, 2H, CH2-10); C NMR (151 MHz, CDCl3) δ: 17.50 (C-4), 21.93 (CH3-6), 25.08 and 27.38 (CH3)2C<), 37.55 (C-2), 38.61 (C-3), 40.10 (C-5), 41.74 (C-6), 46.93 (C-10), 47.82 (C-7), 89.34 (C-1), 176.08 (C-8); IR (KBr, cm-1): 2934 (s), 1773 (s), 1254 (s), 731 (m);

Microbial transformations

Thirty strains of filamentous fungi and yeasts used in this work came from the collection of the Institute of Biology and Botany, Wrocław Medical University (Absidia coerulea AM93, Absidia glauca AM254, Absidia cylindrospora AM336, Armillaria mellea AM296, Beauveria bassiana AM278, Chaetomium sp. AM432, Fusarium avenaceum AM12, Fusarium culmorum AM10, Fusarium culmorum AM196, Fusarium scirpi AM199A, Fusarium solani AM203, Fusarium tricinctum AM16, Laetiporus sulphurens AM524, Mortierella isabellina AM212, Mortierella vinaceae AM149, Mucor circinelloides AM385, Nigrospora oryzae AM8, Penicillium camembertii AM83, Penicillium chermesinum AM113, Penicillium frequentans AM351, Penicillium lilacinum AM111, Penicillium vermiculatum AM81, Pholiota aurivella AM522, Rhodotorula marina AM77, Rhodotorula rubra AM82, Saccharomyces cerevisiae AM464, Spicaria fusispora AM136, Syncephalastrum racemosum AM105, Trametes versicolor AM536) and from the collection of the Department of Phytopatology, Kraków Agricultural University (Cenangium ferruginosum AR56). Cultivation of microorganisms was carried out on Sabouraud agar slants of following composition: aminobac (5.0 g), peptone K (5.0 g), glucose (40.0 g) in distilled water (1 L). The microorganisms were cultivated at 28°C and stored in refrigerator at 4°C.

Screening procedure

The strains were cultivated at 25°C in 300 mL Erlenmeyer flasks containing 50 mL of medium (30.0 g glucose, 5.0 g peptone K, 5.0 g aminobac in 1 L of distilled water). After 4 days of growth 10 mg of iodolactone (1) dissolved in 1 mL of acetone were added to the shaken cultures (150 rpm). The incubation was continued for 15 days. After 1, 2, 3, 6, 9, 12 and 15 days of incubation, the products were extracted with methylene chloride and analyzed by TLC and GC. Three strains of fungi (A. cylindrospora AM336, M. isabellina AM212 and M. vinaceae AM149) were able to transform the iodolactone (1). For selected strains the screening experiments with bromo- (2) and chlorolactone (3) as substrates were carried out as described above.

Biotransformation

The screening experiments allowed as to choose three strains of fungi capable to transform iodo-, bromo- and chlorolactone (1–3) (A. cylindrospora AM336, M. isabellina AM212 and M. vinaceae AM149). For isolation and identification of products, the biotransformation were performed in multiplied scale. Selected strains were cultivated in 10 Erlenmeyer flasks with 50 mL of medium to which 100 mg of substrate dissolved in acetone was totally added (reaction conditions the same as described in screening procedure). After the optimum time for each biotransformation process the products were extracted two times with methylene chloride (50 mL for each flask). The organic layers were pooled, dried over anhydrous MgSO4 and the solvent was evaporated in vacuo. The transformation products were separated and purified by column chromatography (hexane:acetone from 7:1 to 4:1). As a result of biotransformation of (1) in A. cylindrospora AM336 culture, 27 mg (26% yield) of hydroxyiodolactone (4) was obtained, for M. isabellina AM212 and M. vinaceae AM149 21 mg (20% yield) and 19 mg (18% yield), were isolated respectively. Products of bromolactone (2) transformations were isolated in 14% yields (15 mg) using A. cylindrospora AM336, in 24% yield (20 mg) using M. isabellina AM212 and in 16% yield (17 mg) using M. vinaceae AM149. Hydroxylated metabolites of chlorolactone (3) were obtained using A. cylindrospora AM336 culture in 30% yield (32 mg), using M. vinaceae AM149 in 31% yield (33 mg) and using M. isabellina AM212 in 49% yield (52 mg). The physical and spectral data of biotransformation products are given below. (+)-5-Hydroxy-1-iodomethyl-2,2,6-trimethyl-9-oxabicyclo [4.3.0]nonan-8-one (4) White crystals, mp = 168–172°C; = +30.13 (c = 0.45, CH2Cl2, ee = 100%); H NMR (600 MHz, CDCl3) δ: 1.09 and 1.17 (two s, 6H, (CH3)2C<), 1.26 (s, 3H, CH3-6), 1.36 (ddd, J = 13.9, 7.4 and 4.3 Hz, 1H, one of CH2-3), 1.61–1.65 (m, 2H, CH2-4), 1.71 (m, 1H, one of CH2-3), 2.72 and 3.16 (two d, J = 17.8 Hz, 2H, CH2-7), 3.39 (dd, J = 9.4, 6.6 Hz, 1H, H-5), 3.55 and 3.80 (two d, J = 12.0 Hz, 2H, CH2I); C NMR (151 MHz, CDCl3) δ: 5.87 (C-10), 13.47 (CH3-6), 25.28 and 27.52 ((CH3)2C<), 26.44 (C-4), 36.72 (C-3), 38.15 (C-2), 44.64 (C-7), 48.27 (C-6), 75.11 (C-5), 88.91 (C-1), 175.54 (C-8); IR (KBr, cm-1): 3549 (s), 3479 (s), 2981 (s), 1758 (s), 1259 (s), 622 (m). HRMS (ESI-TOF) m/z [M+H]+ calcd for C12H19IO3 339.0457; found 339.0449. (+)-5-Hydroxy-1-bromomethyl-2,2,6-trimethyl-9-oxabicyclo [4.3.0]nonan-8-one (5) White crystals, mp = 165–169°C; = +30.88 (c = 0.5, CH2Cl2, ee = 95%); H NMR (600 MHz, CDCl3) δ: 1.07 and 1.14 (two s, 6H, (CH3)2C<), 1.29 (s, 3H, CH3-6), 1.39 (dt, J = 13.4 and 3.1 Hz, 1H, one of CH2-3), 1.61–1.66 (m, 2H, CH2-4), 1.71 (m, 1H, one of CH2-3), 2.67 and 3.18 (two d, J = 17.9 Hz, 2H, CH2-7), 3.41 (dd, J = 9.1 and 6.9 Hz, 1H, H-5), 3.76 and 3.94 (two d, J = 12.1 Hz, 2H, CH2Br); C NMR (151 MHz, CDCl3) δ: 13.54 (CH3-6), 25.10 and 27.20 ((CH3)2C<), 26.54 (C-4), 35.26 (C-10), 36.94 (C-3), 38.13 (C-2), 44.77 (C-7), 47.88 (C-6), 75.23 (C-5), 89.67 (C-1), 175.88 (C-8); IR (KBr, cm-1): 3485 (s), 2988 (s), 1762 (s), 1259 (s), 661 (m). HRMS (ESI-TOF) m/z [M+H]+ calcd for C12H19BrO3 291.0596; found 291.0599. (+)-3-Hydroxy-1-chloromethyl-2,2,6-trimethyl-9-oxabicyclo [4.3.0]nonan-8-one (6) mp = 152–157°C, = +1.93 (c = 0.73, CH2Cl2, ee = 67%); H NMR (600 MHz, CDCl3) δ: 0.99 and 1.23 (two s, 6H, (CH3)2C<), 1.37 (s, 3H, CH3-6), 1.54–1.65 (m, 3H, CH2-4 and one of CH2-5), 1.72 (m, 1H, one of CH2-5), 2.13 and 3.18 (two d, J = 17.4 Hz, 2H, CH2-7), 3.63 (dd, J = 12.0 and 6.0 Hz, 1H, H-3), 3.93 and 4.08 (two d, J = 12.7 Hz, 2H, CH2Cl); C NMR (151 MHz, CDCl3)δ; 16.34 and 22.40 ((CH3)2C<), 21.82 (CH3-6), 26.22 (C-4), 37.86 (C-5), 41.84 (C-6), 42.93 (C-2), 46.78 (C-10), 47.92 (C-7), 73.48 (C-3), 90.70 (C-1), 175.70 (C-8);); IR(KBr, cm-1): 3508 (s), 2978 (s), 1752 (s), 1269 (s) 731 (m). HRMS (ESI-TOF) m/z [M+H]+ calcd for C12H19ClO3 247.1101; found 247.1114. (+)-5-Hydroxy-1-chloromethyl-2,2,6-trimethyl-9-oxabicyclo [4.3.0]nonan-8-one (7) White crystals, mp = 165–170°C, = +4.33 (c = 1.3, CH2Cl2, ee = 66%); H NMR (600 MHz, CDCl3) δ: 1.05 and 1.12 (two s, 6H, (CH3)2C<), 1.29 (s, 3H, CH3-6), 1.37 (m, 1H, one of CH2-3); 1.59–1.77 (m, 3H, one of CH2-3 and CH2-4), 2.66 and 3.06 (two d, J = 17.9 Hz, 2H, CH2-7), 3.41 (dd, J = 8.7, 7.5 Hz, 1H, H-5), 3.91 and 4.01 (two d, J = 12.7 Hz, 2H, CH2Cl); C NMR (151 MHz, CDCl3) δ: 13.64 (CH3-6), 24.87 and 27.15 ((CH3)2C<), 26.54 (C-4), 36.97 (C-3), 37.58 (C-2), 44.68 (C-7), 47.22 (C-10), 47.51 (C-6), 75.17 (C-5), 90.41 (C-1), 176.10 (C-8); IR (KBr, cm-1): 3491 (s), 2981 (s), 1756 (s), 1261 (s), 733 (m). HRMS (ESI-TOF) m/z [M+H]+ calcd for C12H19ClO3 247.1101; found 247.1113.

Cytotoxic activity

The effect of three halolactones (1, 2, 3) on proliferation of HeLa (provided from Institute Rudjer Boskovic, Zagreb, Croatia) and CHO-K1 (ATCC CCL-61) cells was examined by WST-1 assay. Cells were cultured in DME medium supplemented with 10% (v/v) FBS in the incubator with 5% CO2 and humidified atmosphere at 37°C. HeLa and CHO-K1 cells from exponential growth phase were seeded in 96-well plates at initial concentration of 5 × 10−4 cells per well in 100 μL of media. After 24 h of inoculation, culture media was replaced by fresh one containing 100 and 200 μM of tested lactones. Stock solutions of lactones (1, 2, 3) were prepared in DMSO, and filtered through 0.22 filters. After 72 h of treatment, 10 μL of WST-1 reagent was added to each well and cells were incubated for further 4 h. Absorbance was measured at 450 nm on the microplate reader (Tecan, Switzerland). The experiments were performed in triplicate and data were expressed as means ± S.D. of percentages of treated cells versus control (untreated cells).

Results and discussion

The metabolism of three β-cyclocitral-derived halolactones which exhibit antifeedant activity towards storage product pests [22] was investigated in fungal strains cultures. Preliminary screening procedure was carried out for iodolactone (1). Thirty strains of filamentous fungi and yeast, listed in the experimental part, were checked to select efficient biocatalyst. Among them, three strains: Absidia cylindrospora AM336, Mortierella isabellina AM212 and Mortierella vinaceae AM149 were able to modify the iodolactone structure (). In the next step these selected microorganisms were tested for their ability are to transform also the bromo- and chlorolactone (2 and 3). The results of screening experiments as the composition of product mixtures during the biotransformation processes are presented in . The Mortierella vinaceae AM149 was found to transform all substrates at the highest rate. On the contrary, the longest time of transformation was observed in the case of found for processes catalyzed by Absidia cylindrospora AM336 and even after 15 days substrates were not consumed completely. Based on the data obtained in the screening experiments, the biotransformation processes in multiplied scales were carried out in order to isolate and determine the structures of obtained products. Because of intensification of metabolites production in the last days of processes, we decided to shorten the transformation time to simplify the isolation procedure. The optimal biotransformation time for Absidia cylindrospora AM336 was twelve days, for Mortierella isabellina AM212 and Mortierella vinaceae AM149 nine and three days, respectively. Biotransformation of iodolactone (1) in the culture of all selected fungal strains resulted in the formation of the same (+)-enantiomer of product, but its enantiomeric excess depended on the biocatalyst (). Pure enantiomer of product 4 was produced by M. isabellina AM212. The process catalyzed by A. cylindrospora AM336 was the least enantioselective (ee of product—50%). The isolated yields of the product were rather moderate and did not exceed 26% as obtained in A. cylindrospora AM336—catalyzed transformation. The structure of product was established on the basis of its spectroscopic data (S1–S3 Figs). IR spectrum of lactone 4 showed the presence of absorption band at 1758 cm-1 characteristic for five membered lactone ring and O-H band stretching vibration at 3479 cm-1 confirming the introduction of the hydroxy group. The location of this functional group was determined by comparison of the 1H NMR spectrum of product 4 and parent structure 1. On 1H NMR spectrum of the hydroxyiodolactone (4) characteristic doublets from CH-10 groups can be observed. The presence of those signals excluded the dehalogenation process. Incorporation of hydroxy group into the molecule was additionally confirmed by the deshielding effect of oxygen from OH function which resulted in the shift of characteristic doublet of doublets from H-5 proton to 3.39 ppm. Coupling constant value between one of the CH2-4 protons and H-5 proton (J = 9.4 Hz) suggested the axial orientation of the latter and consequently equatorial location of hydroxy group. The crucial was HMBC correlation, with allowed to confirm the exact location of hydroxy group. The coupling between carbon C-7, CH3-6 and proton H-5, undoubtedly confirms the introduction of the OH group at C-5. Strong similarities can be noticed for biotransformation of bromolactone (2) (). In those processes also the enantiomerically enriched (+)-isomer of hydroxybromolactone (5) was obtained as the only product. The highest enantiomeric excess (ee = 95%) was determined for the product obtained in M. isabellina AM212 culture as in the case of transformation of iodolactone (1). Analogically, the lowest ee value of hydroxybromolactone (5) (ee = 76%) was observed when Absidia cylindrospora AM336 was used as biocatalyst (). The spectroscopic data of the substrate (2) and product of biotransformation (5) (S4–S6 Figs) exhibited differences analogical to those described above for hydroxyiodolactone (4). The presence of absorption bands at 1762 cm-1 and 3549 cm-1 on IR spectrum proved the retention of the γ-lactone moiety and incorporation of hydroxy function. On 1H NMR spectrum at 3.41 ppm the characteristic doublet of doublets from proton H-5 is present. The coupling constant J = 9.1 Hz found in this signal confirmed axial orientation of proton H-5 and as a consequence the equatorial position of hydroxy group. Further, the coupling between the proton H-5 and carbon atoms C-7 and CH3-6 on HMBC spectrum, confirmed the incorporation of OH group into C-5 position. The products of biohydroxylations of chlorolactone 3 () exhibited lower enantiomeric excess (52–67%) compare to iodo- and bromoderivatives (). In all experiments (+)-isomer of product 6 or 7 was the major one. The hydroxychlorolactone 7 obtained in Mortierella isabellina AM212 culture was the product of biohydroxylation of substrate at C-5. The spectral data (S7–S9 Figs) were comparable to those described above for products 4 and 5. Evident similarities like absorption band at 1756 cm-1 and 3491 cm-1 on IR spectrum and correlation between proton H-5 and carbon atoms CH3-6 and C-7 on HMBC spectrum were found. The equatorial orientation of OH group was confirmed on the basis of the signal shape and constant coupling values (J = 8.7 and 7.5 Hz) of proton H-5. Taking into consideration numerous similarities in the biotransformation of δ-iodo-γ-lactone 1 and δ-bromo-γ-lactone 2, the transformation of δ-chloro-γ-lactone 3 in Absidia cylindrospora AM336 and Mortierella vinaceae AM149 cultures resulted in the formation of unexpected product 6 (). The analysis of its spectral data revealed that this time the substrate 3 was hydroxylated at C-3 position of cyclohexane ring (S10–S12 Figs). On HMBC spectrum the crucial confirmation was coupling between C-3 shifted to δ = 73.48 ppm and protons of two geminal methyl groups. Significant difference in chemical shifts can be noticed between the 1H NMR spectra of products 6 and 7. As a result of deshielding effect of oxygen from OH group the signal from the protons of one of methyl group in gem-dimethyl substituent was shifted to the lower field (1.23 ppm) for product of C-3 hydroxylation comparing with 1.12 ppm of hydroxylactone 7. The axial orientation of proton H-3 and consequently equatorial position of hydroxy group is confirmed by constant coupling values (J = 12.0 Hz) found for H-3 signal. The product of biotransformation of chlorolactone 3 were obtained in high isolated yields within the range from 30% in the case of Absidia cylindrospora AM336 to even almost 50% in the case of Mortierella isabellina AM212 culture. The most popular biocatalytic process used to obtain the optically active alcohols is asymmetric reduction of prochiral ketones [25-27] and lipase-catalyzed kinetic resolution of racemic alcohols [28, 29]. In both cases the basic limitation is the presence of carbonyl or hydroxy function already in the defined place in a substrate molecule. In literature we can find numerous examples of enantioselective hydroxylation of inactivated position in steroid skeleton [6, 14, 30, 31] and terpenes [13, 32]. Nevertheless, the regio- and stereoselective incorporation of hydroxy function into smaller non-functionalized molecules is still a challenge [33]. As reported in previous studies, the fungal metabolism of bicyclic lactones with cyclohexane system can be complex and often engages the oxidation reactions. Genus Absidia is one of the most potent biological systems involving different metabolic pathways in transformations processes. The ability of Absidia cylindrospora for catalyzing hydroxylation reactions, various dehalogenation reactions or epoxydation of double bond is well documented. Regardless of the biocatalyst the hydroxy group is commonly incorporated at a tertiary carbon atom [20, 21, 34] or into alkyl substituents [7, 35]. For unsaturated lactones the formation of epoxy products can be observed [20]. Alternatively, halolactones can be subjected to different dehalogenation reactions. These processes lead mainly to the products of hydrolytic dehalogenation in which halogen atom is replaced by hydroxy group [36] or unsaturated lactones as the dehydrohalogenation products [8, 37]. In our work we obtained products of enantioselective hydroxylation of secondary carbon atoms in cyclohexane moiety. All obtained products are not reported previously and what is also worth to notice, unlike C-2, C-3 and C-4 hydroxylations the C-5 biohydroxylation was not described in literature for this group of compounds. Additionally, retention of halogen atom as additional reactive center can be important in context of their possible use as multifunctional chiral building blocks. To confirm possible antiproliferative effect of halolactones (1, 2, 3), we evaluated their in vitro cytotoxicity towards HeLa and CHO-K1 cell lines by WST-1 assay. Obtained results expressed as a percentage of cell viability are presented in . Tested compounds did not show the significant decrease of cell viability in both cell lines even at 200 μM concentration. Nevertheless, the obtained cytotoxicity results are valuable as a guide how to direct the synthesis of similar analogues with improved biological properties.

Effect of halolactones (1, 2, 3) on HeLa and CHO cell viability, determined by the WST-I assay.

The viability (%) was expressed as percentage of treated cells versus control cells.

Conclusion

Among thirty strains of filamentous fungi and yeast three of them: Absidia cylindrospora AM336, Mortierella isabellina AM212 and Mortierella vinaceae AM149 were able to incorporate the hydroxy function into substrate structure. All biotransformation processes were regio- and enantioselective and new hydroxyhalolactones were isolated and fully characterized by spectroscopic data. In all four products the hydroxy group was incorporated in inactivated methylene carbon atom of cyclohexane moiety. The most significant differences between the biocatalysts can be observed during the transformation of chlorolactone (3). Absidia cylindrospora AM336 and Mortierella vinaceae AM149 exhibited the tendency of C-3 hydroxylation and Mortierella isabellina AM212 strain hydroxylated C-5 carbon atom regardless of the halogen type in substrate structure. Presented biohydroxylations is efficient method to obtained enantiomerically pure or enrich hydroxyhalolactones—the multifunctional compounds that potentially can be used as the chiral building blocks.

1H NMR and 13C NMR spectra of hydroxyiodolactone 4.

(PDF) Click here for additional data file.

IR spectrum of hydroxyiodolactone 4.

(PDF) Click here for additional data file.

HRMS spectrum of hydroxyiodolactone 4.

(PDF) Click here for additional data file.

1H NMR and 13C NMR spectra of hydroxybromolactone 5.

(PDF) Click here for additional data file.

IR spectrum of hydroxybromolactone 5.

(PDF) Click here for additional data file.

HRMS spectrum of hydroxybromolactone 5.

(PDF) Click here for additional data file.

1H NMR and 13C NMR spectra of hydroxychlorolactone 7.

(PDF) Click here for additional data file.

IR spectrum of hydroxychlorolactone 7.

(PDF) Click here for additional data file.

HRMS spectrum of hydroxychlorolactone 7.

(PDF) Click here for additional data file.

1H NMR and 13C NMR spectra of hydroxychlorolactone 6.

(PDF) Click here for additional data file.

IR spectrum of hydroxychlorolactone 6.

(PDF) Click here for additional data file.

HRMS spectrum of hydroxychlorolactone 6.

(PDF) Click here for additional data file.
Table 1

The composition (in % according to GC) of the products mixtures in the screening biotransformations of halolactones 1, 2 and 3.

Time of incubation(days)A. cylindrosporaAM336M. isabellina AM212M. vinaceae AM149
Substrate 1Product 4Substrate 1Product 4Substrate 1Product 4
1100057434951
2100044563268
3742636641882
6594121790100
9465413870100
1223774960100
15188201000100
Substrate 2Product 5Substrate 2Product 5Substrate 2Product 5
1100089115248
291963372377
3792134661783
662381882694
942581189397
12227801000100
15148601000100
Substrate 3Product 6Substrate 3Product 7Substrate 3Product 6
198265357921
291954465149
3851539612575
669312278397
942586940100
12277301000100
15138701000100
Table 2

The enantiomeric excess (ee %) of obtained biotransformation products.

StrainProductEeProducteeProductee
A. cylindrosporaAM336(+)-450%(+)-576%(+)-652%
M. isabellina AM212(+)-4100%(+)-595%(+)-766%
M. vinaceae AM149(+)-490%(+)-591%(+)-667%
Table 3

Effect of halolactones (1, 2, 3) on HeLa and CHO cell viability, determined by the WST-I assay.

The viability (%) was expressed as percentage of treated cells versus control cells.

CompoundConcentration
HeLaCHO-K1
100μM200μM100μM200μM
198.89±5.5887.50±3.5497.08±10.61100.85±1.92
297.69±1.7890.13±4.00100.08±6.82100.85±7.29
397.05±2.6592.66±4.9697.19±3.48102.77±3.80
  15 in total

Review 1.  Industrial biotransformations in the synthesis of building blocks leading to enantiopure drugs.

Authors:  D Muñoz Solano; P Hoyos; M J Hernáiz; A R Alcántara; J M Sánchez-Montero
Journal:  Bioresour Technol       Date:  2011-12-14       Impact factor: 9.642

2.  Regio- and stereo-selective hydroxylations of ingenane diterpenoids by Mortierella ramanniana and Gibberella fujikuroi.

Authors:  Yi-Qing Wu; Yue Cao; Xin Liu; Zhi-Hong Cheng
Journal:  Chin J Nat Med       Date:  2016-12

3.  Microbial transformations of halolactones with p-menthane system.

Authors:  Marcelina Mazur; Aleksandra Grudniewska; Czesław Wawrzeńczyk
Journal:  J Biosci Bioeng       Date:  2014-07-12       Impact factor: 2.894

4.  Optically active stereoisomers of 5-(1-iodoethyl)-4-(4'-isopropylphenyl)dihydrofuran-2-one: The effect of the configuration of stereocenters on apoptosis induction in canine cancer cell lines.

Authors:  Aleksandra Pawlak; Witold Gładkowski; Marcelina Mazur; Marta Henklewska; Bożena Obmińska-Mrukowicz; Andrzej Rapak
Journal:  Chem Biol Interact       Date:  2016-11-17       Impact factor: 5.192

5.  Hydroxylation of DHEA and its analogues by Absidia coerulea AM93. Can an inducible microbial hydroxylase catalyze 7α- and 7β-hydroxylation of 5-ene and 5α-dihydro C19-steroids?

Authors:  Natalia Milecka-Tronina; Teresa Kołek; Alina Swizdor; Anna Panek
Journal:  Bioorg Med Chem       Date:  2013-12-08       Impact factor: 3.641

6.  Biotransformation of oleanolic and maslinic methyl esters by Rhizomucor miehei CECT 2749.

Authors:  Antonio Martinez; Alberto Perojil; Francisco Rivas; Andres Parra; Andres Garcia-Granados; Antonia Fernandez-Vivas
Journal:  Phytochemistry       Date:  2015-07-30       Impact factor: 4.072

7.  Efficient asymmetric reduction of 4-(trimethylsilyl)-3-butyn-2-one by Candida parapsilosis cells in an ionic liquid-containing system.

Authors:  Bo-Bo Zhang; Wen-Yong Lou; Wen-Jing Chen; Min-Hua Zong
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

8.  Immobilization and characterization of a new regioselective and enantioselective lipase obtained from a metagenomic library.

Authors:  Robson Carlos Alnoch; Viviane Paula Martini; Arnaldo Glogauer; Allen Carolina dos Santos Costa; Leandro Piovan; Marcelo Muller-Santos; Emanuel Maltempi de Souza; Fábio de Oliveira Pedrosa; David Alexander Mitchell; Nadia Krieger
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

9.  Biotransformation of a potent anabolic steroid, mibolerone, with Cunninghamella blakesleeana, C. echinulata, and Macrophomina phaseolina, and biological activity evaluation of its metabolites.

Authors:  Mahwish Siddiqui; Malik Shoaib Ahmad; Atia-Tul- Wahab; Sammer Yousuf; Narjis Fatima; Nimra Naveed Shaikh; Atta-Ur- Rahman; M Iqbal Choudhary
Journal:  PLoS One       Date:  2017-02-24       Impact factor: 3.240

10.  Fungal strains as catalysts for the biotransformation of halolactones by hydrolytic dehalogenation with the dimethylcyclohexane system.

Authors:  Małgorzata Grabarczyk
Journal:  Molecules       Date:  2012-08-14       Impact factor: 4.411

View more
  2 in total

1.  Processing of NMR and MS metabolomics data using chemometrics methods: a global tool for fungi biotransformation reactions monitoring.

Authors:  Cécile Palaric; Serge Pilard; Jean-Xavier Fontaine; Julien Boccard; David Mathiron; Sébastien Rigaud; Dominique Cailleu; François Mesnard; Yoann Gut; Tristan Renaud; Alain Petit; Jean-Yves Beaumal; Roland Molinié
Journal:  Metabolomics       Date:  2019-07-25       Impact factor: 4.290

2.  Chemoenzymatic Synthesis of Enantiomeric, Bicyclic δ-Halo-γ-lactones with a Cyclohexane Ring, Their Biological Activity and Interaction with Biological Membranes.

Authors:  Marcelina Mazur; Aleksandra Włoch; Fouad Bahri; Hanna Pruchnik; Aleksandra Pawlak; Bożena Obmińska-Mrukowicz; Gabriela Maciejewska; Witold Gładkowski
Journal:  Biomolecules       Date:  2020-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.